Nucleobase Stability and Polymerase Recognition
A R T I C L E S
Compound 1D. 31P NMR (140 MHz, 50 mM Tris, 2 mM EDTA,
pH 7.5 in D2O) δ -6.20 (d, J ) 17.2 Hz), -10.71 (d, J ) 15.8 Hz),
-21.82 (t, J ) 17.1 Hz).
4.80-4.59 (m, 1H), 4.13 (brs, 1H), 3.73 (s, 6H), 3.60-3.31 (m, 6H),
2.90-2.81 (1H, m), 2.63 (1H, t, J ) 6.2 Hz), 2.48-2.46 (2H, m), 1.21-
1.15 (12H, m). 31P NMR (140 MHz, CDCl3) δ 150.6, 149.7. HRMS
(MALDI-FTMS): calcd for C42H48N3O7PSNa (MNa+), 792.2848;
found, 792.2832.
Compound 4B. 1H NMR (300 MHz, CDCl3) δ 8.00-7.89 (3H, m),
7.77 (0.5H, d, J ) 1.8 Hz), 7.74 (0.5H, d, J ) 2.0 Hz), 7.63 (0.5H, d,
J ) 6.2 Hz), 7.52 (1H, t, J ) 7.2 Hz), 7.30-7.21 (4H, m), 7.11 (1H,
d, J ) 7.8 Hz), 6.89 (0.5H, dd, J ) 5.6, 8.2 Hz), 6.72-6.62 (1H, m),
6.53 (0.5H, d, J ) 7.0 Hz), 6.40 (0.5H, d, J ) 7.4 Hz), 5.64 (1H, t, J
) 6.2 Hz), 4.95 (0.5H, brs), 4.73 (1H, brs), 4.60 (1H, d, J ) 2.0 Hz),
4.59-4.57 (0.5H, m), 3.18-2.88 (1H, m), 2.62-2.40 (1H, m), 2.26
(3H, s), 2.17 (1.5H, s), 2.04 (1.5H, s). HRMS (MALDI-FTMS): calcd
for C28H25NO7Na (MNa+), 510.1523; found, 510.1509.
1
Compound 1E. H NMR (300 MHz, CDCl3) δ 7.84 (0.5H, d, J )
7.8 Hz), 7.76 (0.5H, d, J ) 7.4 Hz), 7.64 (1H, d, J ) 5.0 Hz), 7.44
(2H, brs), 7.41-7.18 (8H, m), 6.85-6.79 (4H, m), 6.72 (1H, d, J )
5.8 Hz), 6.48 (1H, d, J ) 7.4 Hz), 4.78-4.60 (1H, m), 4.21 (1H, brs),
3.81-3.35 [12H, m, singlet at 3.78 (6H)], 2.74-2.60 (1H, m), 2.60
(1H, t, J ) 6.2 Hz), 2.42 (1H, t, J ) 6.2 Hz), 2.40-2.20 (1H, m),
1.40-1.11 (9H, m), 1.02 (3H, d, J ) 6.9 Hz). 31P NMR (140 MHz,
CDCl3) δ 150.3, 149.6. HRMS (MALDI-FTMS): calcd for C42H48N3O7-
PSNa (MNa+), 792.2843; found, 792.2840.
1
Compound 2B. H NMR (300 MHz, CDCl3) δ 7.98 (2H, d, J )
6.0 Hz), 7.90 (1H, d, J ) 6.0 Hz), 7.61 (1H, d, J ) 5.7 Hz), 7.48 (1H,
d, J ) 3.0 Hz), 7.28 (2H, d, J ) 6.6 Hz), 7.22 (2H, d, J ) 6.0 Hz),
6.97 (1H, dd, J ) 3.0, 0.6 Hz), 6.79 (1H, dd, J ) 12, 3.9 Hz), 6.46
(1H, d, J ) 5.7 Hz), 5.65-5.62 (1H, m), 4.78-4.60 (2H, m), 4.60
(1H, t, J ) 2.1 Hz), 2.97-2.91 (1H, m), 2.44 (6H, s), 2.39-2.26 (1H,
m). 13C NMR (100 MHz, CDCl3) δ 166.2, 166.1, 152.9, 148.6, 144.4,
144.2, 143.2, 132.8, 129.9, 129.6, 129.3, 129.2, 16.7, 126.4, 126.3,
107.3, 100.8, 85.1, 82.9, 77.4, 77.1, 76.7, 75.1, 64.3, 39.3, 21.7, 21.6.
HRMS (MALDI): calcd for C28H25NO7Na (MNa+), 510.1523; found,
510.1518.
1
Compound 4C. H NMR (400 MHz, CDCl3) δ 7.89 (1H, d, J )
2.0 Hz), 7.80 (1H, d, J ) 7.4 Hz), 7.43 (2H, d, J ) 6.6 Hz), 7.65-
7.28 (7H, m), 6.80 (4H, d, J ) 8.6 Hz), 6.72 (1H, d, J ) 2.0 Hz), 6.65
(1H, t, J ) 6.4 Hz), 6.37 (1H, d, J ) 7.4 Hz), 4.52 (1H, d, J ) 5.8
Hz), 4.06 (1H, d, J ) 3.6 Hz), 3.71 (6H, s), 3.48-3.42 (3H, m), 2.48-
2.41 (1H, m), 2.28-2.17 (1H, m). 13C NMR (100 MHz, CDCl3) δ
158.8, 153.3, 149.0, 148.8, 144.8, 143.3, 136.0, 135.9, 133.3, 130.3,
128.4, 128.2, 127.8, 127.7, 127.1, 113.4, 107.4, 107.3, 100.8, 86.9,
86.7, 85.4, 85.3, 72.3, 63.7, 55.5, 55.4, 42.7. HRMS (MALDI-
FTMS): calcd for C33H31NO7Na (MNa+), 576.1993; found, 576.1973.
1
Compound 2C. H NMR (300 MHz, CDCl3) δ 7.84 (1H, d, J )
6.0 Hz), 7.38 (2H, d, J ) 3.8 Hz), 7.27-7.24 (6H, m), 7.19 (1H, t, J
) 5.4 Hz), 6.83 (4H, d, J ) 6.0 Hz), 6.26 (1H, d, J ) 4.5 Hz), 5.54
(1H, d, J ) 6.3 Hz), 4.49 (1H, dd, J ) 8.1, 3.6 Hz), 3.97 (1H, dd, J )
5.7, 2.4 Hz), 3.35 (2H, d, J ) 4.8 Hz), 2.44-2.38 (1H, m), 2.19-2.12
(1H, m). 13C NMR (100 MHz, CDCl3) δ 160.3, 159.7, 159.0, 145.0,
144.6, 135.7, 135.6, 130.2, 129.9, 128.2, 127.7, 126.8, 115.4, 112.9,
106.5, 96.1, 86.9, 86.6, 85.7, 70.7, 63.0, 54.5, 41.8. HRMS (MALDI):
calcd for C33H31NO7Na (MNa+), 576.1993; found, 576.1988.
Compound 2D. 31P NMR (140 MHz, 50 mM Tris, 2 mM EDTA,
pH 7.5 in D2O) δ -6.66 (d, J ) 17.2 Hz), -10.76 (d, J ) 17.1 Hz),
-21.98 (t, J ) 17.4 Hz).
Compound 4D. 31P NMR (140 MHz, 50 mM Tris, 2 mM EDTA,
pH 7.5 in D2O) δ -6.03 (d, J ) 17.1 Hz), -10.73 (d, J ) 17.2 Hz),
-21.85 (t, J ) 17.2 Hz).
1
Compound 4E. H NMR (300 MHz, CDCl3) δ 7.79 (0.5H, d, J )
7.4 Hz), 7.74 (0.5H, d, J ) 7.4 Hz), 7.69 (1H, s), 7.46 (2H, d, J ) 7.0
Hz), 7.40-7.18 (6H, m), 6.87-6.70 (5H, m), 6.59 (1H, s), 6.26 (1H,
d, J ) 7.4 Hz), 4.69-4.60 (1H, m), 4.20 (1H, s), 3.77 (6H, s), 3.80-
3.37 (7H, m), 2.80-2.59 (1H, m), 2.63 (1H, t, J ) 6.7 Hz), 2.42 (1H,
t, J ) 6.7 Hz), 2.40-2.21 (1H, m), 1.30-1.11 (9H, m), 1.10 (3H, d,
J ) 6.9 Hz). 31P NMR (140 MHz, CDCl3) δ 150.1, 149.6. HRMS
(MALDI-FTMS): calcd for C42H48N3O8PNa (MNa+), 776.3071;
found, 776.3065.
1
Compound 2E. H NMR (300 MHz, CDCl3) δ 7.91 (0.5H, d, J )
7.8 Hz), 7.83 (0.5H, d, J ) 7.8 Hz), 7.47-7.28 (9H, m), 6.96 (1H, s),
6.86 (2H, d, J ) 2.8 Hz), 6.81 (2H, d, J ) 3.0 Hz), 6.70 (1H, dd, J )
25.2, 6.2 Hz), 6.30 (1H, d, J ) 7.8 Hz), 4.68-4.59 (1H, m), 4.21 (1H,
brs), 3.79 (6H, s), 3.78-3.35 (7H, m), 2.80-2.62 (1H, m), 2.61 (1H,
t, J ) 6.4 Hz), 2.43 (1H, t, J ) 6.2 Hz), 2.30-2.18 (1H, m), 1.30-
1.21 (9H, m), 1.19 (3H, d, J ) 6.9 Hz). 31P NMR (140 MHz, CDCl3)
δ 150.2, 149.6. HRMS (MALDI): calcd for C42H48N3O8PNa (MNa+),
776.3071; found, 776.3058.
1
Compound 5B. H NMR (300 MHz, CDCl3) δ 7.96 (d, J ) 8.0
Hz, 2H), 7.90 (d, J ) 7.9 Hz, 2H), 7.67 (d, J ) 5.2 Hz, 1H), 7.55 (d,
J ) 7.6 Hz, 1H), 7.26-7.10 (m, 5H), 6.85 (dd, J ) 8.0, 5.6 Hz, 1H),
6.55 (d, J ) 7.4 Hz, 1H), 5.64 (d, J ) 6.2 Hz, 1H), 4.72 (brs, 2H),
4.61 (s, 1H), 2.91 (dd, J ) 14.0, 5.4 Hz, 1H), 2.37 (s, 3H), 2.33 (s,
3H), 2.40-2.36 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 166.4, 165.9,
158.4, 145.6, 144.5, 144.4, 133.9, 130.3, 129.9, 129.6, 129.3, 127.8,
126.9, 126.5, 124.3, 102.8, 88.5, 85.6, 78.0, 77.4, 76.8, 75.3, 64.6, 39.6,
21.9. HRMS (MALDI-FTMS): calcd for C28H25NO6SNa (MNa+),
526.1300; found, 526.1283.
Compound 3B. To a stirred solution of 2B in toluene (0.1 M) was
added Lawesson’s reagent (1.5 equiv) at room temperature. The
resulting solution was refluxed until the reaction was complete. After
concentration in Vacuo, the residue was purified via flash column
chromatography on silica gel (20-40% ethyl acetate in hexanes) to
afford 3B as a yellow foam. HRMS (MALDI-FTMS): calcd for
C28H25NO6SNa (MNa+), 526.1300; found, 526.1272.
1
Compound 5C. H NMR (300 MHz, CDCl3) δ 7.86 (d, J ) 7.8
Hz, 1H), 7.65 (d, J ) 3.0 Hz, 1H), 7.50-7.11 (m, 11H), 6.83 (d, J )
8.6 Hz, 4H), 6.50 (d, J ) 7.6 Hz, 1H), 4.61 (brs, 1H), 4.38-4.20 (m,
1H), 3.77 (s, 6H), 3.54-3.41 (m, 2H), 2.78-2.72 (m, 1H), 2.36-2.26
(m, 1H). 13C NMR (100 MHz, CDCl3) δ 158.7, 158.5, 145.6, 144.8,
135.9, 135.8, 134.0, 130.4, 129.8, 128.4, 128.2, 127.2, 124.4, 113.4,
103.7, 86.9, 86.8, 85.7, 72.2, 63.7, 55.5, 42.7. HRMS (MALDI-
FTMS): calcd for C33H31NO6SNa (MNa+), 592.1764; found, 592.1744.
Compound 5D. 31P NMR (140 MHz, 50 mM Tris, 2 mM EDTA,
pH 7.5 in D2O) δ -7.64 (d, J ) 17.2 Hz), -10.60 (d, J ) 17.2 Hz),
-22.14 (t, J ) 17.1 Hz).
Compound 5E. 1H NMR (300 MHz, CDCl3) δ 7.73 (dd, J ) 14.0,
7.0 Hz, 1H), 7.38 (d, J ) 5.2 Hz, 1H), 7.42-7.05 (m, 10H), 6.76 (d,
J ) 8.6 Hz, 4H), 6.72-6.60 (m, 1H), 6.37 (d, J ) 7.4 Hz, 1H), 4.62-
4.50 (m, 1H), 4.14 (brs, 1H), 3.70 (s, 6H), 3.65-3.23 (m, 6H), 2.70-
2.53 (m, 2H), 2.38 (t, J ) 6.7 Hz, 1H), 2.30-2.12 (m, 1H), 1.25-1.15
(m, 9H), 1.10 (d, J ) 7.0 Hz, 3H). 31P NMR (140 MHz, CDCl3) δ
150.15, 149.48. HRMS (MALDI-FTMS): calcd for C42H48N3O7PSNa
(MNa+), 792.2848; found, 792.2827.
1
Compound 3C. H NMR (300 MHz, CDCl3) δ 8.42 (d, J ) 7.4
Hz, 1H), 7.44 (d, J ) 2.0 Hz, 1H), 7.37-7.04 (11H, m), 6.75 (d, J )
9.0 Hz), 6.49 (d, J ) 7.4 Hz, 1H), 4.53 (d, J ) 5.8 Hz, 1H), 4.02 (d,
J ) 7.2 Hz, 1H), 3.69 (s, 6H), 3.60-3.31 (m, 2H), 2.87 (brs, 1H),
2.8-2.62 (m, 1H), 2.30-2.21 (m, 1H). 13C NMR (100 MHz, CDCl3)
δ 174.2, 158.8, 154.5, 145.6, 144.7, 135.7, 135.6, 133.1, 130.4, 130.3,
128.4, 128.3, 127.4, 113.5, 110.3, 101.1, 90.7, 87.2, 86.5, 78.0, 77.4,
76.7, 70.1, 62.3, 55.6, 42.2. HRMS (MALDI-FTMS): calcd for C33H31-
NO6SNa (MNa+), 592.1764; found, 592.1733.
Compound 3D. 31P NMR (140 MHz, 50 mM Tris, 2 mM EDTA,
pH 7.5 in D2O) δ -9.25 (d, J ) 17.1 Hz), -10.79 (d, J ) 17.0 Hz),
-22.56 (t, J ) 17.2 Hz).
Compound 3E. 1H NMR (300 MHz, CDCl3) δ 8.50 (dd, J ) 18.0,
7.4 Hz, 1H), 7.48 (d, J ) 1.8 Hz, 1H), 7.40-7.05 (m, 12H), 6.79 (d,
J ) 3.6 Hz, 2H), 6.75 (d, J ) 3.5 Hz, 2H), 6.44 (d, J ) 5.8 Hz, 1H),
9
J. AM. CHEM. SOC. VOL. 125, NO. 32, 2003 9645